For instance, funding for biodefense
by the National Institute of Allergy and Infectious Diseases (NIAID) increased from $3.
is a Department of Defense central contractor that researches, develops, and commercializes leading-edge biotechnology.
Beyond the shortsightedness and injustice of prioritizing "bioterror diseases" over basic health needs in the US and abroad, there are many more reasons to be deeply concerned about the biodefense
Anthrax (24%), smallpox (32%) and viral hemorrhagic fever (39%) contributed a total of 95% of the molecules to the biodefense
A group of center member researchers with expertise in biodefense
and emerging infectious diseases research is required to lead the research thrust that underlies all the other activities of the RCE.
Analysis of government funding levels in the US and Europe and information on current grants available for biodefense
With a more streamlined procurement process and the establishment of a National Biodefense
Science Board, among other items, the BARDA bill is clearly a significant and positive step forward in strengthening our nation's bio-security strategy.
We welcome the opportunity to continue to work closely with the Department of Health and Human Services to meet the strategic biodefense
requirements of the Government.
NYSE:EBS), a biopharmaceutical company that develops vaccines and therapeutics for biodefense
and commercial applications and manufactures the only anthrax vaccine approved by the U.
SRI will provide five years of support for the development of treatments for avian flu, SARS, West Nile virus, hepatitis, and biodefense
pathogens and toxins.
The DTRA contract provides funding for our preclinical development efforts into the biodefense
arena, while preserving and enhancing our opportunity in the civilian market for the treatment of resistant bacteria," said John Hollway, Achaogen's Vice President of Business Development.
Previously, he served at the White House as a Director for Biodefense
on the Homeland Security Council where he was responsible for conducting the Biodefense
The company will use the additional financing to fund development of human clinical assays and commercialization of biodefense
This appropriation, combined with earlier funding from the government, supports the goal of Alnylam Biodefense
to build a robust platform for developing RNAi therapeutics to combat natural or man-made biological threats that pose a potential risk to public health and national security.
3 million to support the development of its biodefense